ライフサイエンスコーパス: fecal incontinence

1 ntify phenotypes in defecatory disorders and fecal incontinence.

2 to guide the initial management of men with fecal incontinence.

3 Some patients reported symptoms of fecal incontinence.

4 colon, but 3 were subsequently reversed for fecal incontinence.

5 erformed in 28 women (aged 27-74 years) with fecal incontinence.

6 No patient developed fecal incontinence.

7 s and management of defecatory disorders and fecal incontinence.

8 ledge about the long-term outcome of SNS for fecal incontinence.

9 younger group developed ischemic colitis and fecal incontinence.

10 pproach might be used to treat patients with fecal incontinence.

11 uropathy) are not included within functional fecal incontinence.

12 function ranging from fecal urgency to frank fecal incontinence.

13 an cause urge-related or diarrhea-associated fecal incontinence.

14 pplies to the experience of individuals with fecal incontinence.

15 s to measure severity and quality of life in fecal incontinence.

16 al sphincter muscle as a method for treating fecal incontinence.

17 s outcome variables in therapeutic trials of fecal incontinence.

18 risk factors common to both constipation and fecal incontinence.

19 and ileal pouch reconstruction can result in fecal incontinence.

20 and constipation are known risk factors for fecal incontinence.

21 o, more sucralfate-treated patients reported fecal incontinence (16% v 34%, respectively; P =.04) and

22 us bowel movements/week and </= 1 episode of fecal incontinence/2 weeks, from study weeks 5-8 (respon

23 55.1% in the placebo group had a history of fecal incontinence; 60.4% and 55.1% in the prucalopride

24 (84%), weight loss (77%), fatigue (71%), and fecal incontinence (62%).

25 Urinary and fecal incontinence affect 50% or more of nursing home re

26 Fecal incontinence affects between 1% and 16% of women,

27 dverse events included vomiting, urinary and fecal incontinence, agitation, combativeness, a labile l

28 ables determination of the anatomic cause of fecal incontinence, allowing the surgeon to select patie

29 tify ways to counteract the social stigma of fecal incontinence and assist physicians in providing pa

30 has been advocated as therapy for refractory fecal incontinence and for anorectal reconstruction to a

31 d that target anal canal resting pressure in fecal incontinence and hypersensitivity to distention in

32 on of quality-of-life issues associated with fecal incontinence and improved assessment and communica

33 Both rates of fecal incontinence and obstructed defecation decreased s

34 and advice to patients around the world with fecal incontinence and other gastrointestinal disorders,

35 th dynamic muscle plasty in the treatment of fecal incontinence and total anal reconstruction.

36 % of women (95% CI, 7.3%-10.7%) experiencing fecal incontinence, and 2.9% of women (95% CI, 2.1%-3.7%

37 was the greatest risk factor for developing fecal incontinence, and fecal incontinence was the great

38 enced swallowing difficulties, tinnitus, and fecal incontinence, and he had undergone cataract surger

39 elvic floor disorders (urinary incontinence, fecal incontinence, and pelvic organ prolapse) affect ma

40 Quality of life, fecal incontinence, and satisfaction with surgery were p

41 diverticulitis, enhanced recovery protocols, fecal incontinence, and single incision laparoscopic sur

42 sorption, anal sphincter dysfunction causing fecal incontinence, and the irritable bowel syndrome.

43 e and/or innervation insufficient to explain fecal incontinence, and/or (3) normal or disordered bowe

44 agnosing functional anorectal disorders (ie, fecal incontinence, anorectal pain, and disorders of def

45 Separate cost estimates for fecal incontinence are not available.

46 Corresponding data on men with fecal incontinence are sparse.

47 dure for patients with refractory, end-stage fecal incontinence as well as for patients who require a

48 ting of strategies for primary prevention of fecal incontinence associated with childbirth, and furth

49 utcome of sacral nerve stimulation (SNS) for fecal incontinence at 5 years after implantation and to

50 x, constituting moderate to severe leakage), fecal incontinence (at least monthly leakage of solid, l

51 It is recommended that outcome measures for fecal incontinence be more clearly defined, that future

52 Treatments for fecal incontinence (biofeedback, sphincteroplasty, antid

53 t (biofeedback) has been reported to improve fecal incontinence but has not been compared with standa

54 oaches may benefit a subset of patients with fecal incontinence, but more controlled studies are need

55 encopresis with or without constipation and fecal incontinence caused by anatomic or organic disease

56 creased stool frequency or fewer episodes of fecal incontinence compared to handsewn IPAA, which exci

57 71%, 50%, and 66% for patients with acquired fecal incontinence, congenital incontinence, and total a

58 reviewed recent publications in the areas of fecal incontinence, constipation, single incision and ro

59 Surgical therapies for fecal incontinence continue to evolve and show promise i

60 gested that psychological symptoms can cause fecal incontinence, data are lacking to support a causat

61 mpounds offering new treatment approaches to fecal incontinence, development and testing of strategie

62 ogen levels can contribute to development of fecal incontinence (FI) in women after menopause by alte

63 Chronic diarrhea with fecal incontinence (FI) is a severe, underreported, and

64 The epidemiology of fecal incontinence (FI) is incompletely understood.

65 nce 1997, and in Europe for both urinary and fecal incontinence (FI) since 1994.

66 alence of different types and frequencies of fecal incontinence (FI), describe demographic factors, a

67 nd management of common anorectal disorders: fecal incontinence (FI), functional anorectal pain and f

68 cutaneous tibial nerve stimulation (PTNS) in fecal incontinence (FI).

69 be as effective as stimulation at the ST for fecal incontinence (FI).

70 rtain chronic illnesses are risk factors for fecal incontinence (FI).

71 This need is especially great for fecal incontinence, for which there is much less health

72 Surgical treatment of fecal incontinence has evolved from colostomy and direct

73 Fecal incontinence (hazard ratio [HR], 1.78; 95% confide

74 c floor retraining by biofeedback therapy in fecal incontinence; however, the predictive value of imp

75 Conservative therapy for fecal incontinence improves continence, quality of life,

76 ses the diagnosis and treatment of pediatric fecal incontinence in 4 main categories: (1) Functional

77 und is extremely useful in the evaluation of fecal incontinence in men.

78 hysical activity to improve constipation and fecal incontinence in nursing home residents.

79 The most common cause of fecal incontinence in otherwise healthy women is damage

80 The etiology of fecal incontinence in women is almost exclusively from o

81 Specific diseases associated with fecal incontinence include diabetes, multiple sclerosis,

82 Salvage options for patients with refractory fecal incontinence include passive or electrically stimu

83 Risks of tumor spillage and fecal incontinence induced by transanal extraction are n

84 Fecal incontinence is a challenging condition with numer

85 Functional fecal incontinence is a common, but underrecognized symp

86 Fecal incontinence is a significant source of morbidity

87 Fecal incontinence is a symptom attributable to a variet

88 Functional fecal incontinence is defined as the uncontrolled passag

89 The incidence of fecal incontinence is high in children up to the age of

90 he most important tool in the "treatment" of fecal incontinence is its prevention, which should be th

91 eedback techniques used to treat urinary and fecal incontinence lack standardization.

92 mpered by heterogeneity in the definition of fecal incontinence, lack of consensus on what constitute

93 (4) Children with spina bifida and fecal incontinence may benefit from techniques that teac

94 For fecal incontinence, more significant treatment results w

95 Night-time fecal incontinence occurred less frequently in the stapl

96 Fecal incontinence occurs when the normal anatomy or phy

97 , and amount of stool loss and the impact of fecal incontinence on coping mechanisms and lifestyle/be

98 She denies fecal incontinence or change in stool caliber.

99 ofeedback retraining include the duration of fecal incontinence, pudendal nerve damage, patient age,

100 ality of life was assessed with the Rockwood Fecal Incontinence Quality of Life questionnaire.

101 All patients were evaluated with the Wexner Fecal Incontinence Questionnaire after stoma closure.

102 The median Wexner fecal incontinence score was 9 (possible range: 0-20), a

103 Fecal incontinence seems to be a problem.

104 nction was measured quantitatively and using Fecal Incontinence Severity Index (FISI).

105 The validated Fecal Incontinence Severity Index was added to NHANES in

106 s of the multifaceted mechanisms maintaining fecal incontinence should be incorporated as outcome var

107 physiologic factors that predict response to fecal incontinence therapy would be helpful in choosing

108 of furthering research activities related to fecal incontinence through the National Institutes of He

109 pacitating fecal urgency and associated urge fecal incontinence (UFI).

110 eir 20s or 30s typically do not present with fecal incontinence until their 50s.

111 actor for developing fecal incontinence, and fecal incontinence was the greatest risk factor for deve

112 Nausea, diarrhoea, constipation, and fecal incontinence were all much more common (p<0.0001)

113 n January 1995 and January 1998, 37 men with fecal incontinence were evaluated in the John Radcliffe

114 A total of 171 patients with fecal incontinence were randomized to 1 of 4 groups: (1)

115 Before surgery, 22 patients (32%) reported fecal incontinence, which improved after surgery in 15 c

116 of toileting assistance on the frequency of fecal incontinence, while significant, are less dramatic

117 s by far the most prominent association with fecal incontinence, with a prevalence approaching 50%.

118 recent surgical options for the treatment of fecal incontinence within the context of established the